Agilon Health, Inc. (NYSE:AGL - Get Free Report) passed below its 50 day moving average during trading on Wednesday. The stock has a 50 day moving average of $91.70 and traded as low as $84.42. Agilon Health shares last traded at $91.4230, with a volume of 788,650 shares changing hands.
Wall Street Analyst Weigh In
AGL has been the topic of several research analyst reports. Robert W. Baird set a $116.00 price target on shares of Agilon Health in a research note on Thursday, August 6th. StoneX boosted their price target on shares of Agilon Health from $140.00 to $145.00 and gave the company a "buy" rating in a research report on Wednesday, November 11th. Weiss Ratings restated a "sell (e+)" rating on shares of Agilon Health in a research note on Monday, August 24th. Wells Fargo & Company raised their price objective on Agilon Health from $146.00 to $170.00 and gave the stock an "overweight" rating in a report on Friday, November 13th. Finally, Zacks Research raised Agilon Health from a "hold" rating to a "strong-buy" rating in a report on Friday, November 13th. One analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, six have given a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of "Hold" and an average price target of $107.38.
View Our Latest Report on AGL
Agilon Health Stock Down 20.6%
The business's fifty day moving average price is $91.70 and its 200 day moving average price is $70.29. The company has a quick ratio of 1.13, a current ratio of 1.13 and a debt-to-equity ratio of 0.06. The firm has a market capitalization of $1.54 billion, a PE ratio of -16.47 and a beta of 3.10.
Agilon Health (NYSE:AGL - Get Free Report) last released its quarterly earnings results on Wednesday, November 4th. The company reported $1.97 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($1.23) by $3.20. The firm had revenue of $1.52 billion for the quarter, compared to analyst estimates of $1.46 billion. Agilon Health had a negative return on equity of 51.97% and a negative net margin of 1.45%. On average, equities research analysts forecast that Agilon Health, Inc. will post -1.87 earnings per share for the current fiscal year.
Institutional Inflows and Outflows
Several hedge funds and other institutional investors have recently modified their holdings of the stock. Allworth Financial LP lifted its holdings in shares of Agilon Health by 11.8% during the third quarter. Allworth Financial LP now owns 1,184 shares of the company's stock worth $94,000 after purchasing an additional 125 shares during the period. Sterling Capital Management LLC purchased a new position in Agilon Health in the 3rd quarter valued at $33,000. Root Financial Partners LLC purchased a new position in Agilon Health in the 3rd quarter valued at $57,000. State of Alaska Department of Revenue acquired a new position in Agilon Health in the 3rd quarter valued at $64,000. Finally, Inspire Investing LLC increased its stake in Agilon Health by 31.2% in the 3rd quarter. Inspire Investing LLC now owns 8,048 shares of the company's stock valued at $641,000 after buying an additional 1,912 shares during the period.
Agilon Health Company Profile
(
Get Free Report)
Agilon Health is a U.S. healthcare company that partners with primary care physicians to provide care for patients enrolled in Medicare Advantage plans. Its model is designed to help physician groups move from traditional fee-for-service care toward value-based care, in which providers are rewarded for improving patients' health and coordinating their care. The company provides participating physician groups with clinical, operational, technology and administrative support, along with resources to manage patient populations and coordinate care across local healthcare networks.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Agilon Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Agilon Health wasn't on the list.
While Agilon Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.
This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.